Holen Sie sich die Stockscreener-App
109.16
0.62%
0.67
Handel nachbörslich:
109.16
Schlusskurs vom Vortag:
$108.49
Offen:
$108.49
24-Stunden-Volumen:
100.16K
Relative Volume:
0.48
Marktkapitalisierung:
$2.49B
Einnahmen:
$249.60M
Nettoeinkommen (Verlust:
$57.73M
KGV:
43.42
EPS:
2.5139
Netto-Cashflow:
$74.47M
1W Leistung:
+2.14%
1M Leistung:
+1.65%
6M Leistung:
+24.77%
1J Leistung:
+36.83%
1-Tages-Spanne:
$107.53
$109.71
1-Wochen-Bereich:
$105.50
$110.45
52-Wochen-Spanne:
$71.42
$115.33
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
109.16 | 2.47B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
452.58 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.32 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.63 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.88 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.93 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LMAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - MarketBeat
SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Is LeMaitre Vascular, Inc. (LMAT) a good stock to buy now? - MSN
LMAT Stock Price, Quote & Chart | LEMAITRE VASCULAR INC (NASDAQ:LMAT) - ChartMill
Gainers Report: Is LeMaitre Vascular Inc a strong candidate for buy and hold2026 EndofMonth & Weekly High Return Stock Forecasts - baoquankhu1.vn
LeMaitre Vascular, Inc. (LMAT): A bull case theory - MSN
Why (LMAT) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre (NASDAQ: LMAT) director receives dividend equivalent rights awards - Stock Titan
Dividend equivalents boost LeMaitre Vascular (LMAT) director stock awards - Stock Titan
LeMaitre Vascular (LMAT) director granted new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded dividend equivalent rights - Stock Titan
LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights - Stock Titan
LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants - Stock Titan
LeMaitre Vascular (LMAT) CFO granted new dividend equivalent rights - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CEO receives dividend equivalent rights grants - Stock Titan
Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 - Yahoo Finance
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? - insidermonkey.com
JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LeMaitre Vascular Executive Stock SaleMarch 2026 UpdateNews and Statistics - IndexBox
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo! Finance Canada
LeMaitre Vascular Executive Stock Transaction Analysis - Intellectia AI
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - The Motley Fool
Vanguard disaggregates holdings; LMAT ownership shown as 0% (Vanguard) - Stock Titan
LeMaitre Vascular (LMAT)'s technical outlook is bright after key golden cross - MSN
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Bought by Tudor Investment Corp ET AL - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Congress Asset Management Co. - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Is It Too Late To Consider LeMaitre Vascular (LMAT) After Its Recent Share Price Surge? - simplywall.st
LeMaitre Vascular declares $0.20 dividend - MSN
Assessing LeMaitre Vascular (LMAT) Valuation After Strong Recent Share Price Momentum - simplywall.st
LeMaitre Vascular Inc (NASDAQ:LMAT) Passes Key Quality Investing Screens - ChartMill
Insider Sell: David Roberts Sells Shares of LeMaitre Vascular In - GuruFocus
LeMaitre Vascular (LMAT) SVP exercises options, sells 2,625 shares - Stock Titan
LeMaitre Vascular (LMAT) president sells 3,311.68 shares in open market trade - Stock Titan
Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre (NASDAQ: LMAT) CFO exercises dividend rights and uses shares for taxes - Stock Titan
LMAT (NASDAQ) Form 144: Trent Kamke plans sale of 2,625 shares via option exercise - Stock Titan
Director sale: 8,464 shares by David B. Roberts (LMAT) - Stock Titan
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat
First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st
Why Is LeMaitre Vascular, Inc. (LMAT) Stock Down Today? - Meyka
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lemaitre Vascular Inc-Aktie (LMAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kamke Trent G | Senior V. P., Operations |
Mar 11 '26 |
Sale |
108.50 |
2,625 |
284,812 |
6,677 |
| Roberts David B | President and Director |
Mar 11 '26 |
Sale |
107.68 |
3,312 |
356,586 |
14,667 |
| LeBlanc Dorian Paul | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
0.00 |
2 |
0 |
2,400 |
0.50%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):